Integral Diagnostics Limited
ITGDF
$0.98
-$1.05-51.78%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 129.13M | 128.72M | 119.90M | 117.41M | 82.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 129.13M | 128.72M | 119.90M | 117.41M | 82.39M |
| Cost of Revenue | 88.53M | 88.25M | 82.07M | 80.36M | 57.02M |
| Gross Profit | 40.60M | 40.47M | 37.84M | 37.05M | 25.37M |
| SG&A Expenses | 7.39M | 7.37M | 6.35M | 6.22M | 4.79M |
| Depreciation & Amortization | 12.11M | 12.07M | 10.57M | 10.35M | 7.66M |
| Other Operating Expenses | 4.97M | 4.95M | 5.01M | 4.91M | 3.56M |
| Total Operating Expenses | 118.20M | 117.82M | 107.87M | 105.63M | 75.75M |
| Operating Income | 10.93M | 10.90M | 12.03M | 11.78M | 6.64M |
| Income Before Tax | 4.58M | 4.56M | 3.61M | 3.53M | 125.40K |
| Income Tax Expenses | 1.63M | 1.63M | 1.94M | 1.90M | 254.50K |
| Earnings from Continuing Operations | 2.95M | 2.94M | 1.67M | 1.64M | -129.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -5.60K | -5.60K | -46.80K | -45.80K | -- |
| Net Income | 2.94M | 2.93M | 1.62M | 1.59M | -129.00K |
| EBIT | 10.93M | 10.90M | 12.03M | 11.78M | 6.64M |
| EBITDA | 18.34M | 18.29M | 16.28M | 15.94M | 11.46M |
| EPS Basic | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 |
| EPS Diluted | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.02 | 0.02 | 0.00 |
| Average Basic Shares Outstanding | 371.70M | 371.70M | 365.74M | 365.74M | 247.50M |
| Average Diluted Shares Outstanding | 374.81M | 374.81M | 372.94M | 372.94M | 247.50M |
| Dividend Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Payout Ratio | 155.38% | 155.38% | 154.59% | 154.59% | -1,924.49% |